» Articles » PMID: 30196989

Uptake of the English Bowel (Colorectal) Cancer Screening Programme: an Update 5 Years After the Full Roll-out

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2018 Sep 11
PMID 30196989
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The initial roll-out of the English Bowel (Colorectal) Cancer Screening programme, during 2006 and 2009, found uptake to be low (54%) and socially graded. The current analysis used data from 2010 to 2015 to test whether uptake is increasing and becoming less socially graded over time.

Methods: Postcode-derived area-level uptake of 4.4 million first-time invitees, stratified by gender and the year of the first invitation (2010-2015), was generated using the National Bowel Cancer Screening System. Data were limited to people aged 60-64 years. Binomial regression tested for variations in uptake by the year of invitation, gender, region, area-based socio-economic deprivation and area-based ethnic diversity.

Results: Overall, the first-time colorectal cancer (CRC) screening uptake across 6 years was 52% (n = 2,285,996/4,423,734) with a decline between 2010 and 2015 (53%, 54%, 52%, 50%, 49%, 49% respectively). Uptake continued to be socially graded between the most and the least deprived area-level socio-economic deprivation quintiles (43% vs 57%), the most and the least area-based ethnic diversity quintiles (41% vs 56%) and men and women (47% vs 56%). Multivariate analysis demonstrated the effects of year, deprivation, ethnicity and gender on uptake. The effect of deprivation was more pronounced in the most deprived area quintile between men and women (40% vs 47%) than the least deprived area quintile (52% vs 62% respectively).

Conclusion: We did not find evidence of change in uptake patterns in CRC screening since its initial launch 10 years ago. The programme is unlikely to realise its full public health benefits and is en route to widening inequalities in CRC outcomes.

Citing Articles

Public acceptability and anticipated uptake of risk-stratified bowel cancer screening in the UK: An online survey.

Taylor L, Dennison R, Usher-Smith J Prev Med Rep. 2024; 48:102927.

PMID: 39634284 PMC: 11614824. DOI: 10.1016/j.pmedr.2024.102927.


Effectiveness of tailored talks between a cancer screening specialist and general practitioners to improve the uptake of colorectal cancer screening in Ancona (Italy) during the pandemic period.

Acuti Martellucci C, Giacomini G, Flacco M, Manzoli L, Morettini M, Martellucci M Eur J Gen Pract. 2024; 30(1):2340672.

PMID: 38618885 PMC: 11020593. DOI: 10.1080/13814788.2024.2340672.


Patient and healthcare professionals' perceptions of a combined blood and faecal immunochemical test for excluding colorectal cancer diagnosis in primary care.

Nelson K, Carter K, Hepburn J, Hill I, Hurlow C, ONeill C Health Expect. 2023; 26(6):2655-2665.

PMID: 37697688 PMC: 10632655. DOI: 10.1111/hex.13796.


Inequalities in cancer screening participation between adults with and without severe mental illness: results from a cross-sectional analysis of primary care data on English Screening Programmes.

Kerrison R, Jones A, Peng J, Price G, Verne J, Barley E Br J Cancer. 2023; 129(1):81-93.

PMID: 37137996 PMC: 10307861. DOI: 10.1038/s41416-023-02249-3.


Inequalities in colorectal cancer screening uptake in Wales: an examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic.

Bright D, Hillier S, Song J, Huws D, Greene G, Hodgson K BMC Public Health. 2023; 23(1):546.

PMID: 36949447 PMC: 10031708. DOI: 10.1186/s12889-023-15345-z.


References
1.
White B, Power E, Ciurej M, Lo S, Nash K, Ormiston-Smith N . Piloting the Impact of Three Interventions on Guaiac Faecal Occult Blood Test Uptake within the NHS Bowel Cancer Screening Programme. Biomed Res Int. 2015; 2015:928251. PMC: 4615211. DOI: 10.1155/2015/928251. View

2.
Hewitson P, Glasziou P, Watson E, Towler B, Irwig L . Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008; 103(6):1541-9. DOI: 10.1111/j.1572-0241.2008.01875.x. View

3.
Weller D, Coleman D, Robertson R, Butler P, Melia J, Campbell C . The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer. 2007; 97(12):1601-5. PMC: 2360273. DOI: 10.1038/sj.bjc.6604089. View

4.
Chambers J, Callander A, Grangeret R, OCarroll R . Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust. BMC Cancer. 2016; 16:96. PMC: 4752755. DOI: 10.1186/s12885-016-2133-4. View

5.
Wardle J, Von Wagner C, Kralj-Hans I, Halloran S, Smith S, McGregor L . Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Lancet. 2015; 387(10020):751-9. PMC: 4761689. DOI: 10.1016/S0140-6736(15)01154-X. View